Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin

Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin

The syndrome in most cases was a progressive state, 15% of patients per year developing dementia, a rate significantly higher than that in the overall population of elderly people.

Scientific Studies & Papers

Author of Study or Paper
Neznamov GG, Teleshova ES.
Source
Neuroscience and behavioral physiology.
About Study
  • Double Blind
  • Placebo Controlled
  • Human Study

Content Copyright 2011 - 2024  LimitlessMindset.com. All Rights Reserved.

  • All trademarks, logos, and service marks displayed are registered and/or unregistered Trademarks of their respective owners.
  • Reproduction in whole or in any form without express written permission is prohibited.
  • This is not medical advice.
  • The content on this website is for entertainment purposes.
  • These statements have not been evaluated by the Food and Drug Administration.
  • These products are not intended to treat, cure, prevent, or diagnose any disease.

Website by Roseland Digital